Luminex, Partners HealthCare Collaborate on Biomarker, Assay Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex today announced a deal with healthcare system Partners HealthCare for the discovery of biomarkers and development of clinical assays.

Partners HealthCare Center for Personalized Genetic Medicine will develop molecular diagnostic assays based on biomarkers discovered within the integrated health system to be run on Luminex's xMAP platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.